background
bovin
coronaviru
bcov
wide
distribut
pathogen
caus
diseas
econom
loss
cattl
industri
worldwid
prevent
viru
spread
imped
lack
basic
knowledg
concern
viral
shed
transmiss
potenti
individu
anim
aim
studi
investig
durat
quantiti
bcov
shed
fece
nasal
secret
relat
clinic
sign
presenc
viru
blood
tissu
test
hypothesi
seroposit
calv
infecti
incontact
calv
three
week
bcov
infect
method
live
anim
experi
conduct
direct
contact
anim
group
h
challeng
procedur
four
calv
commingl
group
six
natur
infect
calv
sequenti
euthan
two
sentinel
calv
commingl
experiment
expos
group
three
week
exposur
nasal
swab
fece
blood
tissu
sampl
analyz
viral
rna
rtqpcr
viru
isol
perform
nasal
swab
serum
analyz
bcov
antibodi
result
calv
show
mild
gener
sign
promin
sign
respiratori
system
overal
clinic
score
correspond
well
shed
viral
rna
first
three
week
challeng
gener
depress
cough
sign
correl
best
shed
bcov
rna
peak
respiratori
rate
peak
rectal
temperatur
appear
week
later
peak
shed
nasal
shed
preced
fecal
shed
calv
detect
amount
viral
rna
intermitt
fece
day
nasal
secret
day
howev
viru
isol
unsuccess
day
six
day
two
calv
investig
viral
rna
detect
blood
found
lymphat
tissu
day
challeng
although
calv
shed
bcov
rna
day
infect
sentinel
anim
infect
conclus
prolong
shed
bcov
rna
occur
detect
viral
rna
necessarili
indic
transmiss
potenti
studi
provid
valuabl
inform
regard
produc
scientif
base
biosecur
advic
bovin
coronaviru
bcov
import
livestock
pathogen
high
preval
worldwid
viru
caus
respiratori
diseas
diarrhea
calv
winter
dysenteri
adult
cattl
diseas
result
substanti
econom
loss
reduc
anim
welfar
one
way
reduc
neg
consequ
viru
prevent
viru
transmiss
herd
interherd
transmiss
possibl
either
directli
via
transfer
live
anim
indirectli
via
contamin
personnel
equip
measur
prevent
viru
spread
herd
must
base
upon
knowledg
viral
shed
potenti
transmiss
suscept
anim
role
protect
immun
sever
observ
studi
publish
bcov
shed
fece
diarrheic
calv
transport
feedlot
howev
rel
studi
bcov
pathogenesi
emphasi
transmiss
potenti
control
condit
publish
bcov
belong
genu
betacoronaviru
within
famili
coronavirida
also
includ
close
relat
caus
respiratori
infect
human
human
pathogen
sarscov
merscov
bcov
consist
one
serotyp
antigen
variat
differ
strain
acut
infect
anim
develop
antibodi
persist
long
period
possibl
sever
year
howev
protect
immun
shorter
incomplet
two
experiment
studi
infect
calv
protect
reinfect
differ
bcov
strain
three
week
first
challeng
develop
clinic
sign
bcov
transmit
via
fecalor
respiratori
rout
infect
epitheli
cell
respiratori
tract
intestin
nasal
turbin
trachea
lung
villi
crypt
small
larg
intestin
respect
replic
lead
shed
viru
nasal
secret
fece
import
factor
pathogenesi
still
fulli
explor
viru
infect
enterocyt
shortli
introduct
anim
viremia
detect
one
studi
park
et
al
clinic
sign
rang
none
sever
includ
fever
respiratori
sign
diarrhea
without
blood
time
infect
usual
unknown
laboratori
diagnost
usual
perform
occurr
clinic
sign
relev
paramet
relat
viral
shed
major
experiment
studi
use
bcov
inocul
challeng
procedur
may
influenc
clinic
sign
viral
shed
therebi
transmiss
potenti
compar
natur
infect
hypothes
bcov
caus
chronic
subclin
infect
could
import
viru
sourc
kapil
et
al
document
viral
antigen
small
larg
intestin
infect
calv
three
week
post
inocul
crouch
et
al
found
ten
cow
shed
bcovimmun
complex
fece
week
howev
difficult
establish
whether
true
persist
viru
reinfect
partial
immun
anim
whether
anim
repres
risk
anim
lack
experiment
studi
investig
viral
shed
pattern
longer
period
two
week
sensit
detect
method
viral
load
infect
also
need
determin
high
practic
relev
sinc
farmer
need
guidanc
biosecur
trade
transport
live
anim
current
studi
conduct
fill
prevail
gap
knowledg
fundament
aspect
bcov
infect
specif
aim
live
anim
experi
natur
host
conduct
experiment
unit
group
calv
intervent
consist
direct
contact
bcovinfect
anim
primari
outcom
clinic
sign
secondari
outcom
presenc
bcov
rna
bcov
antibodi
three
experiment
group
includ
field
group
fg
n
natur
infect
bcov
expos
group
eg
n
sentinel
group
sg
n
overview
studi
design
shown
fig
twelv
bcov
seroneg
wean
bull
calv
six
twelv
week
age
includ
seven
swedish
red
white
four
swedish
holstein
one
swedish
mountain
breed
origin
two
dairi
herd
initi
neg
antibodi
bcov
milk
primipar
cow
calv
alloc
group
accord
herd
origin
day
arriv
sequenc
euthanasia
eg
sg
calv
random
determin
draw
lot
natur
outbreak
winter
dysenteri
fg
origin
herd
earli
phase
winter
dysenteri
outbreak
fg
transport
research
facil
calv
show
mild
sign
respiratori
diseas
two
day
later
sever
outbreak
confirm
rtpcr
serolog
caus
bcov
bloodi
diarrhea
reduct
milk
product
took
place
herd
experi
conduct
stationari
clinic
depart
clinic
scienc
swedish
univers
agricultur
scienc
facil
close
anim
experi
restrict
admiss
peopl
personnel
use
design
cloth
contact
cattl
day
group
hous
separ
pen
within
room
due
type
facil
design
studi
acclimat
period
possibl
group
clinic
examin
sampl
consist
done
order
sg
eg
fg
mimic
standard
manageri
condit
direct
contact
chosen
challeng
procedur
eg
sg
commingl
done
move
eg
two
group
pen
h
effort
made
minim
stress
discomfort
anim
involv
calv
kept
groupwis
pen
straw
bed
fed
commerci
calf
concentr
twice
daili
access
haylag
ad
libitum
anim
monitor
train
anim
technician
veterinarian
least
three
time
day
indic
antibiot
treatment
iu
procain
benzyl
penicillinkg
bodyweightday
im
five
consecut
day
abnorm
sound
lung
auscult
prolong
high
temperatur
indic
treatment
nonsteroid
antiinflammatori
drug
metacam
vet
boehring
ingelheim
vetmedica
germani
sever
depress
oral
fluid
electrolyt
given
moder
dehydr
anim
euthanasia
achiev
iv
inject
pentobarbit
euthasol
vet
le
vet
netherland
daili
clinic
examin
perform
veterinarian
clinic
sign
score
present
fig
timelin
experi
solid
line
symbol
timespan
calv
particip
experi
dash
line
symbol
commingl
indic
anim
h
eg
field
group
arriv
research
facil
day
commingl
expos
group
day
left
research
facil
day
calv
expos
group
sequenti
euthan
day
day
sentinel
group
arriv
research
facil
day
commingl
expos
group
follow
hour
score
categori
ad
give
daili
clinic
score
calv
experi
score
six
three
consecut
day
moder
diseas
score
eleven
categor
sever
clinic
diseas
nasal
swab
specimen
fecal
sampl
fg
collect
approxim
everi
third
day
day
eg
nasal
swab
fecal
sampl
collect
everi
day
everi
third
day
nasal
swab
sg
collect
nasal
specimen
collect
rotat
flock
copan
brescia
itali
approxim
five
cm
insid
one
calf
nostril
specimen
frozen
store
process
blood
drawn
jugular
vein
upon
arriv
use
steril
evacu
tube
without
edtaanticoagul
edtablood
centrifug
cell
fraction
store
separ
process
sera
store
analyz
tissu
sampl
lung
medial
retropharyng
mesenter
lymph
node
ileum
colon
store
rnalat
serum
sampl
analyz
anti
bcov
igg
svanovir
bcvab
boehring
ingelheim
svanova
uppsala
sweden
accord
manufactur
instruct
sampl
sg
also
test
antibodi
bovin
respiratori
syncyti
viru
brsv
svanovir
brsvab
boehring
ingelheim
optic
densiti
od
nm
measur
correct
subtract
od
neg
control
percent
posit
pp
calcul
sampl
odposit
control
od
ppvalu
regard
neg
fecal
sampl
dilut
pb
nasal
swab
specimen
centrifug
x
g
min
rna
extract
supernat
plasma
qiaamp
viral
rna
mini
qiacub
kit
qiagen
hilden
germani
elut
frozen
rna
blood
cell
fraction
calf
calf
extract
qiazol
qiagen
chloroform
phase
separ
mix
ethanol
purifi
use
rneasi
mini
kit
column
qiagen
rna
extract
mg
tissu
sampl
use
rneasi
plu
univers
mini
kit
qiagen
rtqpcr
perform
use
rna
onestep
quantit
rtpcr
system
invitrogen
usa
two
microlit
rna
ad
reaction
volum
contain
nm
forward
revers
primer
nm
taqman
probe
thermal
profil
includ
rt
step
min
follow
min
thereaft
cycl
conduct
rtqpcr
perform
stratagen
agil
technolog
ca
usa
posit
neg
control
includ
run
order
evalu
inhibit
rtqpcr
rna
extract
fecal
sampl
dilut
compar
undilut
rna
ctvalu
sampl
suggest
neglig
level
inhibitor
inhibitor
plasma
cell
extract
evalu
spike
mengoviru
rna
comparison
ctvalu
show
plasma
neg
effect
cell
fraction
inhibitori
effect
give
increas
one
ctvalu
order
estim
number
bcov
viral
rna
copi
vrc
clinic
sampl
standard
curv
prepar
use
tenfold
dilut
plasmid
contain
bcov
target
sequenc
aliquot
bcov
rna
use
calibr
includ
everi
rtqpcr
plate
adjust
inter
plate
variat
number
vrc
clinic
sampl
calcul
use
formula
q
viral
rna
copi
sampl
q
c
viral
rna
copi
calibr
ct
ct
valu
sampl
ct
c
ct
valu
calibr
slope
standard
curv
standard
curv
cover
rang
plasmid
copi
show
strong
linear
relationship
high
coeffici
determin
r
high
amplif
effici
limit
quantif
loq
plasmid
copi
repres
log
bcov
vrc
per
nasal
swab
ml
plasma
log
vrcg
fece
log
vrcg
tissu
viru
infect
test
viru
isol
nasal
swab
swab
supernat
dilut
dulbecco
modifi
eagl
medium
dmem
thermo
fisher
scientif
paisley
scotland
filter
filter
sartoriu
stedim
biotech
goettingen
germani
ad
monolay
human
rectal
tumor
cell
attcc
plate
addit
infect
viru
titrat
one
nasal
swab
supernat
use
twofold
endpoint
dilut
plate
h
incub
inoculum
replac
dmem
fetal
calf
serum
antibiot
iu
penicillin
mg
streptocillin
ml
two
day
co
cell
fix
intracellular
fixat
buffer
ebiosi
ca
usa
stain
dilut
monoclon
mous
anticoronaviru
antibodi
label
fluorescein
isothiocyn
biox
diagnost
rochefort
belgium
dapi
nuclear
counterstain
thermo
fischer
scientif
well
observ
fluoresc
microscop
antigen
posit
cell
overview
clinic
sign
group
present
tabl
five
six
fg
calv
show
mild
clinic
diseas
eg
daili
clinic
score
shown
fig
three
four
eg
calv
show
mild
diseas
one
calf
moder
clinic
diseas
sg
develop
clinic
sign
categor
diseas
clinic
score
system
howev
calv
day
intermitt
nasal
discharg
sporad
cough
day
intermitt
runni
fece
bloodting
diarrhea
nasal
discharg
observ
group
calv
test
neg
antibodi
bcov
begin
trial
calv
fg
eg
seroconvert
addit
file
tabl
sg
still
seroneg
bcov
show
increas
titer
antibodi
brsv
bcov
rna
detect
blood
sampl
analyz
nasal
shed
bcov
rna
fg
eg
present
fig
fig
show
eg
calv
individu
shed
briefli
fg
shed
bcov
rna
eg
swab
posit
least
one
four
calv
posit
fig
two
calv
posit
nasal
swab
concentr
log
log
vrcswab
day
commingl
sg
none
nasal
swab
sg
posit
fecal
shed
bcov
rna
fg
eg
shown
fig
individu
shed
eg
fig
viral
rna
detect
fecal
sampl
fg
fecal
sampl
eg
neg
least
two
four
calv
posit
everi
day
bcov
rna
intermitt
detect
three
calv
period
four
six
day
neg
result
start
shed
bcov
rna
three
five
day
fig
associ
bcov
pcr
result
select
clinic
sign
shown
fig
overal
clinic
score
show
good
correl
detect
bcov
rna
gener
depress
cough
individu
score
show
best
associ
bcov
rna
shed
highest
mean
respiratori
rate
rectal
temperatur
appear
week
later
peak
shed
calv
expos
bcov
field
expos
fanim
expos
eanim
peak
rectal
temperatur
rt
b
runni
wateri
stool
consid
diarrheic
c
mucopurul
purul
nasal
discharg
nasal
discharg
score
five
day
im
treatment
iu
procain
benzylpenicillin
initi
indic
day
e
calf
treat
six
day
viral
rna
detect
lymph
node
eg
calv
euthan
three
four
five
six
week
infect
tabl
viral
rna
also
detect
ileum
colon
anim
euthan
five
six
week
infect
lung
tissu
viru
isol
nasal
swab
calf
period
photograph
infect
cell
shown
fig
titer
infect
bcov
nasal
swab
per
swab
medium
ml
total
correspond
log
infect
particl
swab
contain
log
vrc
give
total
infect
particl
ratio
ti
log
present
studi
show
calv
infect
bcov
shed
viral
rna
five
week
harbor
viral
rna
intestin
tissu
lymph
node
even
longer
interestingli
contact
calv
three
week
challeng
clinic
condit
improv
calv
seroconvert
lead
infect
sentinel
calv
viru
isol
possibl
calv
shed
viral
rna
time
point
concord
studi
eg
calv
becam
bcov
posit
shortli
contact
infect
calv
shed
viral
rna
continu
two
week
support
introduct
bcov
popul
lead
high
basic
reproduct
number
r
r
depend
durat
infecti
period
number
expos
suscept
individu
probabl
suscept
individu
infect
herd
transport
system
cattl
differ
herd
commingl
risk
viru
transmiss
high
detect
bcov
rna
nasal
swab
calv
eg
shortli
exposur
might
due
passiv
inhal
viru
excret
fg
viru
replic
respiratori
tract
sinc
viral
load
nasal
swab
eg
exceed
fg
studi
confirm
bcov
replic
massiv
airway
eg
calv
alreadi
fecal
shed
start
later
nasal
shed
concurr
studi
saif
colleagu
found
inocul
calv
intranas
bcov
first
detect
nasal
epitheli
cell
secondli
fece
contrast
calv
inocul
oral
fecal
detect
bcov
preced
detect
nasal
swab
specimen
conclud
infect
rout
could
determin
sequenc
infect
respiratori
intestin
tract
present
studi
support
respiratori
rout
common
infect
rout
calv
natur
infect
direct
contact
indirect
viru
spread
fecalor
rout
could
common
nasal
swab
often
posit
bcov
fecal
sampl
trial
like
due
higher
limit
detect
bcov
fece
nasal
swab
diagnost
purpos
nasal
swab
specimen
therefor
seem
advantag
fecal
sampl
viru
detect
calv
suspect
bcov
relat
diseas
move
commingl
associ
stress
found
affect
intestin
immun
system
possibl
stress
increas
bcov
rna
shed
observ
eg
calv
introduct
sentinel
calv
buy
sell
calv
often
involv
extend
transport
commingl
suscept
cattl
stress
respons
possibl
increas
fecal
shed
viru
would
probabl
higher
field
condit
shed
viru
convent
rear
piglet
gnotobiot
piglet
indic
secondari
pathogen
chang
microbiota
import
diseas
develop
clinic
sign
present
studi
support
acut
stage
diseas
factor
viru
replic
import
clinic
sign
instanc
secondari
bacteri
infect
although
sentinel
calv
get
infect
bcov
show
sporad
unspecif
sign
trial
mildest
categori
mild
diseas
clinic
score
system
sinc
acclimat
possibl
calv
chang
environ
includ
feed
routin
enrol
experi
could
caus
sign
observ
infecti
agent
could
also
present
like
less
virul
pathogen
bovin
viru
diarrhea
viru
bovin
herpesviru
present
sweden
sentinel
calv
show
serolog
respons
brsv
coinfect
bcov
agent
likewis
possibl
fg
eg
case
field
condit
unlik
enter
virus
bcov
envelop
therefor
suscept
environment
inactiv
one
might
expect
condit
forestomach
abomasum
would
inactiv
bcov
one
possibl
bcov
transport
oronas
caviti
small
intestin
bloodstream
howev
viremia
detect
present
studi
transport
viru
intestin
appear
digest
tract
park
colleagu
detect
bcov
rna
serum
sampl
calv
infect
winter
dysenteri
strain
day
three
eight
post
inocul
use
nest
pcr
detect
gener
sensit
method
rtqpcr
also
vulner
contamin
short
virem
period
intak
lower
viru
dose
natur
infect
calv
could
also
explain
neg
result
present
studi
inhibit
rtqpcr
plasma
compon
test
rule
despit
absenc
detect
viremia
present
studi
bcov
rna
found
mesenter
lymph
node
late
stage
infect
viral
rna
must
transfer
low
concentr
blood
lymph
drain
lymph
node
antigen
present
cell
free
viru
particl
find
bcov
rna
lymph
node
ileum
colon
six
week
infect
indic
coronaviru
persist
calv
howev
import
persist
viru
transmiss
uncertain
coronavirus
known
creat
persist
chronic
infect
mice
cat
merscov
shown
excret
month
human
human
coronaviru
creat
persist
infect
vitro
although
fecal
shed
bcov
rna
detect
five
week
post
infect
present
studi
transmiss
potenti
stage
like
neglig
three
week
post
infect
bcov
vrc
quantifi
rtqpcr
give
inform
number
infect
particl
ratio
total
infect
particl
ti
challeng
establish
bcov
due
difficulti
cultiv
viru
clinic
sampl
present
studi
viru
titrat
show
ti
ratio
approxim
tissu
sampl
lymph
node
lung
ileum
colon
harvest
expos
group
calv
euthan
indic
number
day
exposur
field
group
calv
number
viral
rna
copi
vrc
bcov
quantifi
rtqpcr
limit
quantif
log
vrcg
tissu
log
high
ti
ratio
surpris
viru
isol
unsuccess
vrc
number
decreas
also
agre
sentinel
calv
get
infect
contrast
roughli
log
vrc
detect
per
nasal
swab
gram
fece
seroneg
fg
calv
infect
eg
calv
ti
ratio
log
nasal
swab
gram
fece
contain
log
infect
viru
particl
high
ti
ratio
failur
viru
isol
could
due
either
infect
particl
low
sensit
isol
method
low
level
infect
particl
could
caus
either
high
product
defect
particl
neutral
effect
antibodi
low
sensit
could
caus
suboptim
condit
cell
cultur
compar
vivo
particularli
viru
clinic
sampl
adapt
cell
cultur
growth
dilut
viral
content
swab
freez
thaw
materi
felin
enter
coronaviru
ti
increas
log
first
week
infect
log
day
post
infect
increas
possibl
caus
antibodi
respons
method
avail
studi
transmiss
potenti
apart
live
anim
experi
although
ethic
challeng
resourc
demand
exist
literatur
base
experiment
studi
examin
bcov
shed
day
author
knowledg
present
studi
first
studi
shed
long
six
week
experiment
condit
addit
also
first
studi
impact
shed
use
sentinel
calv
although
low
number
calv
use
result
indic
calv
infecti
three
week
exposur
bcov
inform
import
relev
order
produc
scientif
base
advic
avoid
introduct
bcov
herd
investig
calv
differ
stage
diseas
recommend
verifi
corrobor
find
effect
stress
relat
transport
viral
shed
infect
also
consid
present
studi
viru
caus
winter
dysenteri
adult
cattl
primarili
gave
respiratori
diseas
calv
niskanen
et
al
also
found
bcov
deriv
outbreak
winter
dysenteri
caus
mainli
respiratori
diseas
wean
calv
support
bcov
import
caus
respiratori
diseas
calv
winter
dysenteri
adult
econom
welfar
consequ
bcov
therefor
includ
combin
effect
neonat
enter
respiratori
diseas
young
cattl
winter
dysenteri
adult
also
consid
high
preval
worldwid
bcov
import
lossinflict
factor
cattl
industri
current
studi
show
calv
infect
bcov
rtqpcr
posit
nasal
fecal
specimen
longer
period
earlier
recogn
howev
contact
calv
three
week
exposur
lead
infect
low
level
infect
particl
could
due
either
product
high
level
defect
particl
andor
product
neutral
antibodi
studi
provid
highli
relev
inform
design
biosecur
advic
regard
anim
trade
coronavir
diseas
cattl
addit
file
tabl
antibodi
bcov
docx
kb
